On Demand 2020 Saturday General Sessions

This collection covers general sessions from Saturday's program. This includes plenaries, symposia, and workshops. The sessions listed below are included in this package:

  • It's Time to Individualize Our Approach to Diagnosis and Testing
  • An International Perspective on Cutting Edge Food Allergy Research
  • Nuts and Bolts of Telemedicine
  • School Health for the Allergist
  • What's That Rash? Doctor, What's Wrong With My Skin?
  • The Not on Thursday Program - Part 1
  • The Not on Thursday Program - Part 2

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 12.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Target Audience

Medical professionals who treat patients with allergic and/or immunological conditions:

  • Practicing allergist/immunologists
  • Allergy/immunology Fellows-in-Training
  • Physician assistants
  • Nurses and advanced practice nurses
  • Allied health professionals
  • Primary care physicians
  • Other medical professionals

Learning Objectives

Upon completion of this session, participants should be able to:

  • Educate patients regarding their personal risk associated with food allergen exposure in various scenarios
  • Identify which component tests are best utilized according to clinical history
  • Recognize common dermatologic conditions that have origins or overlap with allergic and immunologic disorders
  • Identify the key predictors of food allergy prevalence and persistence of food allergy from a large population-based study
  • Describe the roles of vitamin D and maternal dietary intervention on food allergy prevention
  • Detail the outcomes associated with cross-desensitization in tree nut oral immunotherapy
  • Discuss how use has evolved (e.g. examples of conditions, uses, formats)
  • Describe practical tips on how to establish a telemedicine program in their office
  • Describe practical tips for how to navigate reimbursement
  • Recognize the importance of healthy schools and healthy students and how allergists can work with local schools to improve the health of their patients
  • Understand the unique challenges of food avoidance in schools, risks for anaphylaxis in school and barriers to appropriate treatment
  • Recognize the role for school-based asthma management programs and the importance of educating parents and the community about asthma management
  • Define basic dermatology terms
  • Recognize skin lesions that look alike
  • Develop an appropriate treatment plan
  • Apply knowledge of the pathophysiology of cough to assist in treatment decisions
  • Order diagnostic testing according to patient-specific factors associated with chronic cough
  • Discuss the risks, benefits and expected outcomes of various treatment options with patients
  • Utilize available biomarkers to assist decision-making regarding biologic therapies for asthma
  • Consider biologic therapies for patients with severe atopic determatitis
  • Incorporate biologic treatment for patients with severe refractory atopic dermatitis.
Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma & Immunology (ACAAI) policy, the College must identify and resolve conflicts of interest for all individuals responsible for the development, management, presentation, and/ or evaluation relevant to a CME activity. Disclosed information is reviewed in advance in order to manage and resolve any potential conflicts of interest. Disclosure in no way implies that the information presented is biased or of lesser quality; it is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations.

Specific disclosure information for the 2020 Annual Meeting is available online and via the meeting app.

Course summary
Available credit: 
  • 12.75 AMA PRA Category 1 Credit™
  • 12.75 Attendance
  • 12.75 CBRN
Course opens: 
11/17/2020
Course expires: 
11/30/2023
Rating: 
0

Mark L. Corbett, MD, FACAAI
Elissa M. Abrams, MD
Giorgio Walter Canonica, MD
Luz S. Fonacier, MD, FACAAI
James M. Tracy, DO, FACAAI
Ruchi Gupta, MD, MPH
Benjamin Prince, MD
Jennifer Koplin, MD, PhD
Kirsten Perret, MBBS, FRACP, PhD
Arnon Elizur, MD
Jay M. Portnoy, MD, FACAAI
David M. Lang, MD, FACAAI
Jennifer A. Shih, MD
Tania Elliot, MD, FACAAI
Sakina S. Bajowala, MD 
Bruce J. Lanser, MD, FACAAI
Irene Mikhail, MD
Michael Pistiner, MD, MMSc, FACAAI
Julie Wang, MD, FACAAI
Sujani Kakumanu, MD
Kelly M. Maples, MD, FACAAI
James Treat, MD
Stephanie L. Mawhirt, DO
Alan B. Goldsobel, MD, FACAAI
David R. Stukus, MD, FACAAI
Mandel R. Sher, MD, FACAAI
William C. Anderson, MD, FACAAI
Leonard B. Bacharier, MD, FACAAI
John J. Oppenheimer, MD, FACAAI
Brian T. Kelly, MD, MA, FACAAI
Anju T. Peters, MD
Mark Boguniewicz, MD, FACAAI 
David M. Fleischer, MD, FACAAI
Jaclyn Smith, MB, ChB, PhD
Kaiser Lim, MD
Peter Dicpinigaitis, MD
Thomas B. Casale, MD, FACAAI
Stanley J. Szefler, MD, FACAA

Available Credit

  • 12.75 AMA PRA Category 1 Credit™
  • 12.75 Attendance
  • 12.75 CBRN
Please login or create an account to take this course.